Keeping Your Nose in Front: The Medicine Maker

Over the past few years, the pharmaceutical industry has become increasingly aware of the advantages nasal drug delivery could provide for their target product, patient population, and indication. In turn, this trend is fuelling the demand for experienced, specialist contractors to support the rise in inhalation formulation development.

In this article with The Medicine Maker, Dr. Charles Evans, Vice President of Pharmaceutical Development at MedPharm, explores how nasal drug delivery can help put the patient at the center of your development strategy and how this can help you keep your nose ahead of the competition.

Access the full article here.

About MedPharm

MedPharm is the world’s leading contract provider of topical and transdermal formulation development and manufacturing services. Our experts specialize in reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through cost-effective and industry-leading performance testing models. Well-established as the global leader in dermal and transdermal product development, MedPharm also offers innovative solutions for airway, ophthalmic, otic, ungual, and other topical preparations. With locations in both the US and the UK, MedPharm is the CDMO of choice for developers around the globe.